No Record Found
Sector
PharmaceuticalsOpen
₹1,444.2Prev. Close
₹1,426.5Turnover(Lac.)
₹3,575.91Day's High
₹1,465Day's Low
₹1,38552 Week's High
₹1,519.952 Week's Low
₹889Book Value
₹172.23Face Value
₹10Mkt Cap (₹ Cr.)
26,749.5P/E
62.45EPS
22.83Divi. Yield
0.21Here are some of the stocks that may see significant price movement today: GAIL (India), Adani Ports and SEZ, Spandana Sphoorty, etc.
Here are some of the stocks that may see significant price movement today: Emcure Pharma, Tata Power, One 97 Communications, etc.
The price stated is a discount of about 7% to Emcure Pharma’s closing price of ₹1,394.10 on the NSE on November 17, 2025.
This is a second brand of Wegovy® (semaglutide injection 2.4 mg), in a move aimed at expanding access to its anti-obesity therapy across the country.
Here are some of the stocks that may see significant price movement today: Tech Mahindra, L&T Technology, Maruti Suzuki, etc.
| Y/e 31 Mar( In .Cr) | Mar-2025 | Mar-2024 | Mar-2023 | Mar-2022 |
|---|---|---|---|---|
Equity Capital | 189.48 | 181.15 | 180.85 | 180.85 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 2,834.88 | 1,753.95 | 1,661.02 | 1,531.68 |
Net Worth | 3,024.36 | 1,935.1 | 1,841.87 | 1,712.53 |
Minority Interest |
No Record Found
No Record Found
No Record Found
| Particulars (Rupees in Crores.) | Mar-2025 | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
|---|---|---|---|---|---|
Gross Sales | 7,896 | 6,658.25 | 5,985.81 | 5,855.39 | 6,056.42 |
Excise Duty | 0 | 0 | 0 | 0 | 0 |
Net Sales | 7,896 | 6,658.25 | 5,985.81 | 5,855.39 | 6,056.42 |
Other Operating Income | 0 | 0 | 0 | 0 | 0 |
Other Income | 67.26 | 56.99 | 45.91 | 63.47 | 35.39 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
|---|---|---|---|---|---|---|---|
Sun Pharmaceutical Industries Ltd SUNPHARMA | 1,755.9 | 90.1 | 4,21,131.27 | 564.22 | 0.91 | 4,511.27 | 99.24 |
Divis Laboratories Ltd DIVISLAB | 6,476.5 | 68.36 | 1,71,861.7 | 696 | 0.46 | 2,660 | 578.26 |
Torrent Pharmaceuticals Ltd TORNTPHARM | 3,820.1 | 60.56 | 1,29,248.2 | 597 | 0.16 | 2,707 | 249.83 |
Cipla Ltd CIPLA | 1,500.7 | 23.32 | 1,21,197.99 | 1,210.53 | 1.07 | 4,495.16 | 411.56 |
Dr Reddys Laboratories Ltd DRREDDY | 1,283.5 | 19.84 | 1,07,083.08 | 387.3 | 0.62 | 4,602.9 | 377.56 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Whole Time Director
MUKUND KESHAO GURJAR
Whole Time Director
SUNIL RAJNIKANT MEHTA
Managing Director & Chief Executive Officer
SATISH RAMANLAL MEHTA
Chairman (Non-Executive)
Berjis M Desai
Whole Time Director
NAMITA VIKAS THAPAR
Independent Director
P S Jayakumar
Independent Director
Vijay Gokhale
Independent Director
Vidya Rajiv Yeravdekar
Independent Director
Shailesh Ayyangar
Whole-time Director
SAMIT SATISH MEHTA
Plot # P-1 & P-2 IT BT Park,
Phase II MIDC Hinjawadi,
Maharashtra - 411057
Tel: +91 20 3507 0033/+91 20 3507 0000
Website: http://www.emcure.com
Email: investors@emcure.com
C-101 247 Park,
L B S Marg, Vikhroli West,
Mumbai-400083
Tel: 91-22-49186000
Website: https://in.mpms.mufg.com
Email: rnt.helpdesk@in.mpms.mufg.com
Summary
Emcure Pharmaceuticals Limited was originally incorporated as Emcure Pharmaceuticals Private Limited, as a Private Company, pursuant to a Certificate of Incorporation dated April 16, 1981 issued by Re...
Read More
Reports by Emcure Pharmaceuticals Ltd
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor), PFRDA Reg. No. PoP 20092018

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.